We partner with leading research institutes and biotechnology companies to acquire innovative drug candidates. Our goal is to embed these therapies seamlessly into clinical workflows, with a focus on outpatient care. We follow evidence-based decision making and advance only those programs that meet our rigorous internal criteria — prioritizing both medical efficacy and affordability. We also work to ensure our therapies are broadly accessible and covered maximally by medical insurance and/or medical subsidies.